{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T01:47:36Z","timestamp":1791683256173,"version":"4.3.4"},"reference-count":129,"publisher":"SAABRON PRESS","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Factor XIII (FXIII) deficiency is a rare bleeding disorder characterized by unstable hemostatic clots due to defective fibrin cross\u2011linking. Congenital FXIII deficiency arises from variants in the F13A1 (FXIII-A subunit) or F13B (FXIII-B subunit) genes, and classically presents with delayed umbilical stump hemorrhage, soft\u2011tissue and intracranial bleeding, impaired wound healing, and recurrent pregnancy loss. Acquired deficiency stems from inhibitory autoantibodies or from reduced synthesis or consumption in critical illness and surgery. Routine coagulation screening tests are normal and diagnosis relies on quantitative FXIII activity assays with or without antigenic phenotyping and, when indicated, inhibitor testing and molecular confirmation. Plasma\u2011derived FXIII concentrate reduces spontaneous and intracranial bleeding; recombinant FXIII\u2011A2 is appropriate for F13A1 defects but not patients with F13B variants. Perioperative and obstetric care target activity thresholds suited to procedural risk and individual pharmacokinetics. This review synthesizes the molecular biology, epidemiology, clinical features, diagnostic methods, and evidence\u2011based management of FXIII deficiency, with practical guidance for assay selection, validation, and result interpretation.<\/jats:p>","DOI":"10.46989\/001c.155180","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:08:11Z","timestamp":1768914491000},"source":"Crossref","is-referenced-by-count":7,"title":["Factor XIII Deficiency: A Review of Biology, Testing, and Treatment"],"prefix":"10.46989","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5719-9685","authenticated-orcid":true,"given":"Jeremy W.","family":"Jacobs","sequence":"first","affiliation":[{"name":"Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN, USA"},{"name":"Special Coagulation Laboratory, Vanderbilt Medical Laboratories, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8422-9480","authenticated-orcid":false,"given":"Garrett S.","family":"Booth","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Costa","sequence":"additional","affiliation":[{"name":"Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina A.","family":"Figueroa Villalba","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA"},{"id":[{"id":"https:\/\/ror.org\/01njes783","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Laboratory Medicine and Pathology, Seattle Children\u2019s Hospital, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3304-9965","authenticated-orcid":false,"given":"Bipin N.","family":"Savani","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05dq2gs74","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9480-2762","authenticated-orcid":false,"given":"Brian D.","family":"Adkins","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine and Hemostasis, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"26435","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/ijlh.14144","article-title":"Viscoelastic testing: Critical appraisal of new methodologies and current literature","volume":"45","author":"G. D. Wool","year":"2023","journal-title":"Int J Lab Hematol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12959-016-0076-2","article-title":"Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity","volume":"14","author":"G. J. Kuiper","year":"2016","journal-title":"Thromb J"},{"issue":"10","key":"ref3","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1016\/j.jtha.2023.05.005","article-title":"A new global fibrinolysis capacity assay for the sensitive detection of hyperfibrinolysis and hypofibrinogenemia in trauma patients","volume":"21","author":"A. Rossetto","year":"2023","journal-title":"J Thromb Haemost"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"101032","DOI":"10.1016\/j.blre.2022.101032","article-title":"Genetic landscape in coagulation factor XIII associated defects - Advances in coagulation and beyond","volume":"59","author":"H. Javed","year":"2023","journal-title":"Blood Rev"},{"issue":"1","key":"ref5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/mbc.0000000000000679","article-title":"Molecular diagnosis of factor XIII deficiency, data from comprehensive coagulation laboratory in Iran","volume":"29","author":"M. Gheidishahran","year":"2018","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"ref6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1055\/s-0036-1572326","article-title":"Diagnosis and management of congenital and acquired FXIII deficiencies","volume":"42","author":"L. Muszbek","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/s0049-3848(13)70005-7","article-title":"Corifact\u2122\/Fibrogammin\u00ae P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study","volume":"130 Suppl 2","author":"D. Nugent","year":"2012","journal-title":"Thromb Res"},{"key":"ref8","article-title":"CORIFACT Prescribing Information","author":"U.S. Food & Drug Administration","journal-title":"Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration"},{"key":"ref9","article-title":"TRETTEN (catridecacog) Prescribing Information","author":"U.S. Food & Drug Administration","journal-title":"Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration"},{"issue":"2","key":"ref10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2450\/2014.0024-14","article-title":"Diagnosis and management of severe congenital factor XIII deficiency in the Emergency Department: lessons from a \"model\" family","volume":"13","author":"M. Bertamino","year":"2015","journal-title":"Blood Transfus"},{"issue":"6","key":"ref11","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1111\/j.1365-2516.2008.01857.x","article-title":"Factor XIII deficiency","volume":"14","author":"L. Hsieh","year":"2008","journal-title":"Haemophilia"},{"issue":"1","key":"ref12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/trf.12784","article-title":"Use of Factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures","volume":"55","author":"M. Janbain","year":"2015","journal-title":"Transfusion"},{"issue":"5","key":"ref13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000446813","article-title":"Safety of factor XIII concentrate: Analysis of more than 20 years of pharmacovigilance data","volume":"43","author":"C. Solomon","year":"2016","journal-title":"Transfus Med Hemother"},{"issue":"3","key":"ref14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/mbc.0000000000000029","article-title":"Factor XIII deficiency management: a review of the literature","volume":"25","author":"J. E. Odame","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"8892225","DOI":"10.1155\/2020\/8892225","article-title":"Management of neuraxial analgesia in a parturient with factor XIII deficiency: A case report and proposed management algorithm","volume":"2020","author":"D. B. Carroll","year":"2020","journal-title":"Case Rep Anesthesiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1182\/blood-2023-189442","article-title":"Neuraxial Analgesia in Pregnant Individuals with Bleeding Disorders: A Comprehensive Examination of Obstetric Anesthesia Practices and Outcomes","volume":"142","author":"Y. Yi","year":"2023","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bcmd.2019.04.006","article-title":"A retrospective study on clinical manifestations of neonates with FXIII-A deficiency","volume":"77","author":"M. Naderi","year":"2019","journal-title":"Blood Cells Mol Dis"},{"issue":"6","key":"ref18","doi-asserted-by":"publisher","first-page":"e417","DOI":"10.1111\/hae.13603","article-title":"Challenges in diagnosis and management of acquired factor XIII (FXIII) inhibitors","volume":"24","author":"J. D. Beckman","year":"2018","journal-title":"Haemophilia"},{"issue":"3","key":"ref19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tmrv.2016.04.001","article-title":"Acquired factor XIII inhibitor in hospitalized and perioperative patients: A systematic review of case reports and case series","volume":"30","author":"K. J. Tone","year":"2016","journal-title":"Transfus Med Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-025-03148-5","article-title":"Comparison of outcomes in autoimmune acquired factor XIII deficiency with and without underlying diseases: a systematic review","author":"J. Song","year":"2025","journal-title":"J Thromb Thrombolysis"},{"issue":"10","key":"ref21","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/trf.17501","article-title":"Survey of blood collection and transfusion practices among institutions in Africa","volume":"63","author":"J. W. Jacobs","year":"2023","journal-title":"Transfusion"},{"issue":"6","key":"ref22","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1055\/s-0033-1353392","article-title":"Factor XIII deficiency: an update","volume":"39","author":"V. Schroeder","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"12","key":"ref23","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJMp2403596","article-title":"Ensuring a safe and sufficient global blood supply","volume":"391","author":"J. W. Jacobs","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"ref24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1537-2995.2008.02021.x","article-title":"Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma","volume":"49","author":"J. S. Caudill","year":"2009","journal-title":"Transfusion"},{"issue":"6","key":"ref25","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/j.1537-2995.2010.02632.x","article-title":"Evidence-based practice guidelines for plasma transfusion","volume":"50","author":"J. D. Roback","year":"2010","journal-title":"Transfusion"},{"issue":"17","key":"ref26","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1182\/blood-2018-10-833988","article-title":"Noninfectious transfusion-associated adverse events and their mitigation strategies","volume":"133","author":"R. Goel","year":"2019","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1391422","DOI":"10.3389\/fmed.2024.1391422","article-title":"Are all fibrinogen concentrates the same? The effects of two fibrinogen therapies in an afibrinogenemic patient and in a fibrinogen deficient plasma model. A clinical and laboratory case report","volume":"11","author":"S. Goodarzi","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.thromres.2021.06.020","article-title":"Differences in the biochemical composition of three plasma derived human fibrinogen concentrates","volume":"205","author":"A. Neisser-Svae","year":"2021","journal-title":"Thromb Res"},{"issue":"2","key":"ref29","doi-asserted-by":"publisher","first-page":"102371","DOI":"10.1016\/j.rpth.2024.102371","article-title":"Management of anticoagulation and factor XIII replacement in a patient with severe factor XIII deficiency and recurrent venous thromboembolic disease: case report and review of literature","volume":"8","author":"L. Bounaix","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"ref30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/eja.0000000000001803","article-title":"Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care: Second update 2022","volume":"40","author":"S. Kietaibl","year":"2023","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"ref31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000526489","article-title":"Factor XIII in the Acute Care Setting and Its Relevance in Obstetric Bleeding","volume":"50","author":"P. Duque","year":"2023","journal-title":"Transfus Med Hemother"},{"issue":"5","key":"ref32","doi-asserted-by":"publisher","first-page":"e100262","DOI":"10.1136\/bmjopen-2025-100262","article-title":"Effects of early factor XIII replacement in postpartum hae morrhage: study protocol for a multicentre, open-label, randomised, controlled, investigator-initiated trial","volume":"15","author":"C. Haslinger","year":"2025","journal-title":"BMJ Open"},{"issue":"6","key":"ref33","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.hoc.2021.07.009","article-title":"Factor XIII deficiency: A review of clinical presentation and management","volume":"35","author":"A. Pelcovits","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"ref34","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/j.1537-2995.2012.03865.x","article-title":"Biology of factor XIII and clinical manifestations of factor XIII deficiency","volume":"53","author":"J. H. Levy","year":"2013","journal-title":"Transfusion"},{"issue":"11","key":"ref35","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1182\/blood-2013-10-533596","article-title":"Interaction of factor XIII subunits","volume":"123","author":"E. Katona","year":"2014","journal-title":"Blood"},{"issue":"12","key":"ref36","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3390\/biom9120765","article-title":"The plasma factor XIII heterotetrameric complex structure: Unexpected unequal pairing within a symmetric complex","volume":"9","author":"S. Singh","year":"2019","journal-title":"Biomolecules"},{"issue":"5","key":"ref37","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/jth.14431","article-title":"Factor XIII: What does it look like?","volume":"17","author":"Z. Bagoly","year":"2019","journal-title":"J Thromb Haemost"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"15059","DOI":"10.1038\/hgv.2015.59","article-title":"Characterization of a novel large deletion caused by double-stranded breaks in 6-bp microhomologous sequences of intron 11 and 12 of the F13A1 gene","volume":"3","author":"A. Thomas","year":"2016","journal-title":"Hum Genome Var"},{"issue":"33","key":"ref39","doi-asserted-by":"publisher","first-page":"8656","DOI":"10.1021\/bi8006143","article-title":"Sushi domains in the B subunit of factor XIII responsible for oligomer assembly","volume":"47","author":"M. Souri","year":"2008","journal-title":"Biochemistry"},{"key":"ref40","article-title":"F13A1 coagulation factor XIII A chain (Gene ID: 2162)","author":"National Center for Biotechnology Information","journal-title":"NCBI Gene"},{"issue":"4","key":"ref41","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1152\/ajplegacy.1944.142.4.581","article-title":"A study on the conversion of fibrinogen to fibrin","volume":"142","author":"K. C. Robbins","year":"1944","journal-title":"Am J Physiol"},{"key":"ref42","article-title":"F13B coagulation factor XIII B chain (Gene ID: 2165)","author":"National Center for Biotechnology Information","journal-title":"NCBI Gene"},{"issue":"1","key":"ref43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1538-7836.2010.04070.x","article-title":"Factor XIII: novel structural and functional aspects","volume":"9","author":"I. Kom\u00e1romi","year":"2011","journal-title":"J Thromb Haemost"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/jbm.S32693","article-title":"New developments in the management of congenital Factor XIII deficiency","volume":"4","author":"Z. Fadoo","year":"2013","journal-title":"J Blood Med"},{"issue":"6","key":"ref45","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3324\/haematol.2009.017210","article-title":"Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function","volume":"95","author":"V. Ivaskevicius","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"ref46","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1055\/s-0029-1225765","article-title":"Factor XIII deficiency","volume":"35","author":"M. Karimi","year":"2009","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"ref47","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1182\/blood-2012-07-446393","article-title":"The activation peptide cleft exposed by thrombin cleavage of FXIII-A(2) contains a recognition site for the fibrinogen \u03b1 chain","volume":"121","author":"K. A. Smith","year":"2013","journal-title":"Blood"},{"issue":"8","key":"ref48","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.bbapap.2006.06.007","article-title":"The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma","volume":"1764","author":"A. H. Shemirani","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"ref49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.abb.2011.05.009","article-title":"Role of calcium in the conformational dynamics of factor XIII activation examined by hydrogen-deuterium exchange coupled with MALDI-TOF MS","volume":"512","author":"R. T. Woofter","year":"2011","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"ref50","doi-asserted-by":"publisher","first-page":"11324","DOI":"10.1038\/s41598-019-47815-z","article-title":"Structure functional insights into calcium binding during the activation of coagulation factor XIII A","volume":"9","author":"S. Singh","year":"2019","journal-title":"Sci Rep"},{"issue":"15","key":"ref51","doi-asserted-by":"publisher","first-page":"7296","DOI":"10.1073\/pnas.91.15.7296","article-title":"Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII","volume":"91","author":"V. C. Yee","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref52","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0021-9258(18)70577-2","article-title":"Studies on the polymerization of fibrin; the role of the globulin: fibrin-stabilizing factor","volume":"230","author":"L. Lorand","year":"1958","journal-title":"J Biol Chem"},{"issue":"21","key":"ref53","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.1073\/pnas.83.21.8019","article-title":"Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta","volume":"83","author":"N. Takahashi","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1055\/s-2007-999035","article-title":"Structure and function studies of factor XIIIa by x-ray crystallography","volume":"22","author":"V. C. Yee","year":"1996","journal-title":"Semin Thromb Hemost"},{"issue":"3830","key":"ref55","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1126\/science.160.3830.892","article-title":"Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine","volume":"160","author":"J. J. Pisano","year":"1968","journal-title":"Science"},{"issue":"3","key":"ref56","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1182\/blood-2007-01-066837","article-title":"Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness","volume":"110","author":"K. F. Standeven","year":"2007","journal-title":"Blood"},{"issue":"45","key":"ref57","doi-asserted-by":"publisher","first-page":"28414","DOI":"10.1016\/S0021-9258(18)46943-8","article-title":"Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis","volume":"269","author":"K. R. Siebenlist","year":"1994","journal-title":"J Biol Chem"},{"issue":"18","key":"ref58","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1182\/blood.2020007415","article-title":"Factor XIII cross-links fibrin(ogen) independent of fibrin polymerization in experimental acute liver injury","volume":"137","author":"L. G. Poole","year":"2021","journal-title":"Blood"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1209676","DOI":"10.1155\/2017\/1209676","article-title":"Inhibition of fibrinolysis by coagulation factor XIII","volume":"2017","author":"D. C. Rijken","year":"2017","journal-title":"Biomed Res Int"},{"issue":"35","key":"ref60","doi-asserted-by":"publisher","first-page":"7643","DOI":"10.1021\/bi1010317","article-title":"Noncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin-binding sites","volume":"49","author":"G. Tsurupa","year":"2010","journal-title":"Biochemistry"},{"issue":"9","key":"ref61","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1111\/j.1538-7836.2008.03056.x","article-title":"Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation","volume":"6","author":"M. W. Mosesson","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"3","key":"ref62","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1152\/physrev.00016.2010","article-title":"Factor XIII: a coagulation factor with multiple plasmatic and cellular functions","volume":"91","author":"L. Muszbek","year":"2011","journal-title":"Physiol Rev"},{"issue":"19-20","key":"ref63","doi-asserted-by":"publisher","first-page":"272","DOI":"10.4414\/smw.2007.11756","article-title":"Congenital factor XIII deficiency in Switzerland: from the worldwide first case in 1960 to its molecular characterisation in 2005","volume":"137","author":"V. Schroeder","year":"2007","journal-title":"Swiss Med Wkly"},{"issue":"3","key":"ref64","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1172\/JCI109524","article-title":"Cross-linking of fibronectin to collagen by blood coagulation factor XIIIa","volume":"64","author":"D. F. Mosher","year":"1979","journal-title":"J Clin Invest"},{"issue":"5","key":"ref65","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.blre.2005.01.003","article-title":"The molecular physiology and pathology of fibrin structure\/function","volume":"19","author":"K. F. Standeven","year":"2005","journal-title":"Blood Rev"},{"issue":"6","key":"ref66","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.blre.2016.06.002","article-title":"Blood coagulation factor XIII and factor XIII deficiency","volume":"30","author":"A. Dorgalaleh","year":"2016","journal-title":"Blood Rev"},{"issue":"1-2","key":"ref67","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000093562","article-title":"Role of coagulation factor XIII (FXIII) in angiogenesis and tissue repair","volume":"35","author":"A. Inbal","year":"2006","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"26","key":"ref68","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1182\/blood-2014-06-583070","article-title":"Functional factor XIII-A is exposed on the stimulated platelet surface","volume":"124","author":"J. L. Mitchell","year":"2014","journal-title":"Blood"},{"issue":"1-2","key":"ref69","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0304-3940(95)12188-9","article-title":"Immunohistochemical detection of coagulation factor XIIIa in postmortem human brain tissue","volume":"202","author":"H. Akiyama","year":"1995","journal-title":"Neurosci Lett"},{"issue":"5","key":"ref70","doi-asserted-by":"publisher","first-page":"100200","DOI":"10.1016\/j.rpth.2023.100200","article-title":"Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability","volume":"7","author":"J. L. Mitchell","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"6","key":"ref71","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1182\/blood-2009-06-227645","article-title":"Impaired clot retraction in factor XIII A subunit-deficient mice","volume":"115","author":"K. Kasahara","year":"2010","journal-title":"Blood"},{"issue":"1","key":"ref72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1182\/bloodadvances.2017011890","article-title":"Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice","volume":"2","author":"S. Kattula","year":"2018","journal-title":"Blood Adv"},{"issue":"3","key":"ref73","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1055\/s-0034-1395350","article-title":"Factor XIII deficiency in Iran: a comprehensive review of the literature","volume":"41","author":"A. Dorgalaleh","year":"2015","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"ref74","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1172\/jci106636","article-title":"The effect of fibrin-stabilizing factor on the subunit structure of human fibrin","volume":"50","author":"M. L. Schwartz","year":"1971","journal-title":"J Clin Invest"},{"issue":"2","key":"ref75","doi-asserted-by":"publisher","first-page":"160","DOI":"10.5482\/hamo-13-08-0046","article-title":"Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms","volume":"34","author":"A. Biswas","year":"2014","journal-title":"Hamostaseologie"},{"issue":"2","key":"ref76","doi-asserted-by":"publisher","first-page":"278","DOI":"10.5858\/arpa.2012-0639-RS","article-title":"Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit","volume":"138","author":"A. Tahlan","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2516.2006.01271.x","article-title":"Rare bleeding disorders","volume":"12 Suppl 3","author":"F. Peyvandi","year":"2006","journal-title":"Haemophilia"},{"issue":"4","key":"ref78","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/hae.12340","article-title":"Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations","volume":"20","author":"M. Borhany","year":"2014","journal-title":"Haemophilia"},{"issue":"5","key":"ref79","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/MOH.0b013e3283497e3e","article-title":"Novel aspects of factor XIII deficiency","volume":"18","author":"L. Muszbek","year":"2011","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"ref80","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1160\/TH07-01-0034","article-title":"International registry on factor XIII deficiency: a basis formed mostly on European data","volume":"97","author":"V. Ivaskevicius","year":"2007","journal-title":"Thromb Haemost"},{"issue":"9","key":"ref81","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1111\/jth.13772","article-title":"Minimal factor XIII activity level to prevent major spontaneous bleeds","volume":"15","author":"M. Menegatti","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"3","key":"ref82","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1542\/neo.25-3-e159","article-title":"Intracranial bleeding in a neonate","volume":"25","author":"M. C. Kluge","year":"2024","journal-title":"NeoReviews"},{"issue":"3","key":"ref83","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1055\/s-0037-1604109","article-title":"Intracranial hemorrhage: A devastating outcome of congenital bleeding disorders-prevalence, diagnosis, and management, with a special focus on congenital factor XIII deficiency","volume":"44","author":"S. E. R. Alavi","year":"2018","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"ref84","doi-asserted-by":"publisher","first-page":"5550199","DOI":"10.1155\/2021\/5550199","article-title":"Hemorrhagic shock after neonatal circumcision: Severe congenital factor XIII deficiency","volume":"2021","author":"E. L. Cohen","year":"2021","journal-title":"Case Rep Pediatr"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1749-6632.2001.tb03516.x","article-title":"Factor XIII: structure, activation, and interactions with fibrinogen and fibrin","volume":"936","author":"L. Lorand","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"ref86","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.3390\/ijms22063055","article-title":"Factor XIII-A: An indispensable \"factor\" in haemostasis and wound healing","volume":"22","author":"F. S. M. Alshehri","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.thromres.2019.05.001","article-title":"Contribution of platelets, the coagulation and fibrinolytic systems to cutaneous wound healing","volume":"179","author":"A. Opneja","year":"2019","journal-title":"Thromb Res"},{"issue":"6","key":"ref88","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1111\/hae.12259","article-title":"Congenital factor XIII deficiency in women: a systematic review of literature","volume":"19","author":"L. A. Sharief","year":"2013","journal-title":"Haemophilia"},{"issue":"4","key":"ref89","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1053\/plac.1999.0489","article-title":"Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell","volume":"21","author":"T. Asahina","year":"2000","journal-title":"Placenta"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1365-2516.2011.02561.x","article-title":"Management of pregnancy, labour and delivery in women with inherited bleeding disorders","volume":"17 Suppl 1","author":"F. Y. Huq","year":"2011","journal-title":"Haemophilia"},{"issue":"2","key":"ref91","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1055\/s-2003-38832","article-title":"Coagulation factor deficiencies and pregnancy loss","volume":"29","author":"A. Inbal","year":"2003","journal-title":"Semin Thromb Hemost"},{"issue":"21","key":"ref92","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1182\/blood.V124.21.2852.2852","article-title":"Clinical manifestations and bleeding episodes among heterozygote individuals of factor XIII deficiency, a short term prospective study","volume":"124","author":"M. Naderi","year":"2014","journal-title":"Blood"},{"issue":"6","key":"ref93","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.transci.2018.10.013","article-title":"Acquired factor XIII deficiency: A review","volume":"57","author":"M. T. S. Yan","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"ref94","doi-asserted-by":"publisher","first-page":"e0035","DOI":"10.1097\/ea9.0000000000000035","article-title":"Acquired factor XIII deficiency: A scoping review","volume":"2","author":"O. Duranteau","year":"2023","journal-title":"Eur J Anaesthesiol Intensive Care"},{"issue":"5","key":"ref95","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/jth.12877","article-title":"Anti-factor XIII A subunit (FXIII-A) autoantibodies block FXIII-A2 B2 assembly and steal FXIII-A from native FXIII-A2 B2","volume":"13","author":"M. Souri","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"23","key":"ref96","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1182\/blood-2011-02-333203","article-title":"The antifibrinolytic function of factor XIII is exclusively expressed through \u03b1\u2082-antiplasmin cross-linking","volume":"117","author":"S. R. Fraser","year":"2011","journal-title":"Blood"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1055\/a-2633-0027","article-title":"Immune-related and non-immune-related acquired factor XIII deficiency","author":"A. Ichinose","year":"2025","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"ref98","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s12185-024-03807-y","article-title":"Detection of factor XIII inhibitors in 33 patients with autoimmune factor XIII deficiency in Japan","volume":"120","author":"M. Souri","year":"2024","journal-title":"Int J Hematol"},{"issue":"3","key":"ref99","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/08998280.2006.11928166","article-title":"Case report of an acquired factor XIII inhibitor: diagnosis and management","volume":"19","author":"T. F. Gregory","year":"2006","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"4","key":"ref100","doi-asserted-by":"publisher","first-page":"924A","DOI":"10.1378\/chest.1703383","article-title":"Severe bleeding diathesis from acquired factor XIII inhibitor secondary to SLE","volume":"144","author":"I. Lee","year":"2013","journal-title":"Chest"},{"issue":"3","key":"ref101","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/trf.13947","article-title":"Acquired Factor XIII inhibitor associated with mantle cell lymphoma","volume":"57","author":"C. P. Nixon","year":"2017","journal-title":"Transfusion"},{"issue":"4","key":"ref102","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4103\/hemoncstem.hemoncstem-D-24-00034","article-title":"Acquired factor XIII deficiency in myeloid neoplasms: case series and review of literature","volume":"17","author":"A. Haroon","year":"2024","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"2","key":"ref103","doi-asserted-by":"publisher","first-page":"31","DOI":"10.24911\/ejmcr\/173-1576419538","article-title":"Paraneoplastic factor XIII deficiency in a pregnant female with colon cancer: a case report","volume":"5","author":"C. Schumacher","year":"2021","journal-title":"EJMCR"},{"issue":"1","key":"ref104","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.blre.2016.08.002","article-title":"Autoimmune acquired factor XIII deficiency due to anti-factor XIII\/13 antibodies: A summary of 93 patients","volume":"31","author":"A. Ichinose","year":"2017","journal-title":"Blood Rev"},{"issue":"1","key":"ref105","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13054-022-03940-2","article-title":"The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing","volume":"26","author":"C. Kleber","year":"2022","journal-title":"Crit Care"},{"issue":"3","key":"ref106","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0022-5223(94)70253-5","article-title":"Low factor XIIIA levels are associated with increased blood loss after coronary artery bypass grafting","volume":"108","author":"J. R. Shainoff","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"ref107","doi-asserted-by":"publisher","first-page":"102871","DOI":"10.1016\/j.rpth.2025.102871","article-title":"Understanding blood clot mechanical stability: the role of factor XIIIa-mediated fibrin crosslinking in rupture resistance","volume":"9","author":"R. K. Ramanujam","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"2","key":"ref108","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3349\/ymj.2006.47.2.196","article-title":"Plasma factor XIII activity in patients with disseminated intravascular coagulation","volume":"47","author":"J. W. Song","year":"2006","journal-title":"Yonsei Med J"},{"issue":"1","key":"ref109","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13054-023-04327-7","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition","volume":"27","author":"R. Rossaint","year":"2023","journal-title":"Crit Care"},{"issue":"1","key":"ref110","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1055\/a-1481-2733","article-title":"Acquired FXIII deficiency is associated with high morbidity","volume":"122","author":"P. Duque","year":"2022","journal-title":"Thromb Haemost"},{"issue":"7","key":"ref111","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1111\/j.1538-7836.2011.04315.x","article-title":"Diagnosis and classification of factor XIII deficiencies","volume":"9","author":"H. P. Kohler","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"3","key":"ref112","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3390\/ijms22031002","article-title":"Clinical validation of an automated fluorogenic factor XIII activity assay based on isopeptidase activity","volume":"22","author":"M. Leitner","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"ref113","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2450\/BloodTransfus.902","article-title":"Coagulation factor XIII - last to think about?","volume":"23","author":"T. T. Mahe\u010di\u0107","year":"2025","journal-title":"Blood Transfus"},{"issue":"2","key":"ref114","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1055\/s-0038-1657331","article-title":"The half life of factor XIII in the management of inherited deficiency","volume":"49","author":"J. D. Fear","year":"1983","journal-title":"Thromb Haemost"},{"issue":"7","key":"ref115","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1080\/10245332.2015.1101975","article-title":"Diagnosis of factor XIII deficiency","volume":"21","author":"A. Dorgalaleh","year":"2016","journal-title":"Hematology"},{"issue":"2","key":"ref116","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1055\/s-0034-1365841","article-title":"Factor XIII assays and associated problems for laboratory diagnosis of factor XIII deficiency: an analysis of International Proficiency testing results","volume":"40","author":"P. Hsu","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"ref117","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/mbc.0000000000001326","article-title":"The role of factor XIII in patient blood management","volume":"35","author":"M. \u017duni\u0107","year":"2024","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"ref118","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1172\/jci109671","article-title":"Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor","volume":"65","author":"Y. Sakata","year":"1980","journal-title":"J Clin Invest"},{"issue":"3","key":"ref119","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/bjh.13058","article-title":"Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology","volume":"167","author":"A. D. Mumford","year":"2014","journal-title":"Br J Haematol"},{"issue":"13","key":"ref120","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1182\/blood-2014-08-532820","article-title":"Rare bleeding disorders: diagnosis and treatment","volume":"125","author":"R. Palla","year":"2015","journal-title":"Blood"},{"issue":"11","key":"ref121","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1111\/j.1538-7836.2010.04028.x","article-title":"Factor XIII \u2013 an under diagnosed deficiency \u2013 are we using the right assays?","volume":"8","author":"A. S. Lawrie","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"1","key":"ref122","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ijlh.12756","article-title":"Factor XIII deficiency diagnosis: Challenges and tools","volume":"40","author":"M. Karimi","year":"2018","journal-title":"Int J Lab Hematol"},{"issue":"5","key":"ref123","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1515\/cclm-2015-0547","article-title":"Measurement of factor XIII (FXIII) activity by an automatic ammonia release assay using iodoacetamide blank-procedure: no more overestimation in the low activity range and better detection of severe FXIII deficiencies","volume":"54","author":"M. Cini","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-1-4939-7196-1_22","article-title":"Assessment of factor XIII","volume":"1646","author":"L. Muszbek","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"6","key":"ref125","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.transci.2018.07.006","article-title":"State of the art in factor XIII laboratory assessment","volume":"57","author":"M. A. Durda","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"25","key":"ref126","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1182\/blood.2020004976","article-title":"Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency","volume":"136","author":"A. W. Strilchuk","year":"2020","journal-title":"Blood"},{"issue":"6","key":"ref127","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3390\/jcm11061699","article-title":"Measuring factor XIII inhibitors in patients with factor XIII deficiency: A case report and systematic review of current practices in Japan","volume":"11","author":"S. Amano","year":"2022","journal-title":"J Clin Med"},{"issue":"11","key":"ref128","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.bjae.2022.07.003","article-title":"Point-of-care viscoelastic testing","volume":"22","author":"M. Wells","year":"2022","journal-title":"BJA Educ"},{"issue":"12","key":"ref129","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1182\/blood.2024025321","article-title":"Factor XIII: driving (cross-)links in hemostasis, thrombosis, and disease","volume":"146","author":"J. P. Luyendyk","year":"2025","journal-title":"Blood"}],"container-title":["Clinical Hematology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/chi.scholasticahq.com\/article\/155180-factor-xiii-deficiency-a-review-of-biology-testing-and-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T01:08:08Z","timestamp":1791680888000},"score":1,"resource":{"primary":{"URL":"https:\/\/chi.scholasticahq.com\/article\/155180-factor-xiii-deficiency-a-review-of-biology-testing-and-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":129,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.46989\/001c.155180","relation":{},"ISSN":["2590-0048"],"issn-type":[{"value":"2590-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]}}}